Videos and Masterclasses

At the kickoff meeting of the AF-B-STEP Consortium in Amsterdam, Prof. Paulus Kirchhof spoke with Prof. Daniel Steven, AFNET Steering Committee member, who shared valuable insights into the goals of WP1: driving high-impact, evidence-based dissemination activities to ensure targeted outreach across relevant stakeholder communities and the public.

At the AF-B-STEP Kick-Off Meeting in Amsterdam, Prof. Daniel Steven interviewed John Clifford (IHI) about the project’s role in advancing atrial fibrillation research through a unique public-private collaboration. Over the next four years, the consortium aims to improve AF detection, quantification, and understanding to support better diagnosis and patient outcomes.

In this interview, recorded at the AF-B-STEP Consortium Kick-off Meeting in Amsterdam, we speak with Mirko de Melis – Distinguished Clinical Advisor at Medtronic and Project Leader of AF-B-STEP. Mirko discusses what makes this consortium unique, the industry perspective on AF burden research, key challenges ahead, and his vision for the future of AF monitoring.

We sat down with Project Coordinator Prof. Paulus Kirchhof to talk about the vision behind AF-B-STEP. In this interview, he explains why the binary “yes or no” diagnosis of atrial fibrillation is no longer sufficient in the digital age – and how AF-B-STEP aims to establish AF burden as a clinically meaningful, measurable endpoint for treatment decisions, regulatory approvals, and future clinical guidelines.

In this exclusive interview, Prof. Daniel Steven speaks with Prof. John Camm – one of the world’s leading experts in atrial fibrillation and Chair of the AF-B-STEP Ethics Advisory Board (EAB). The EAB is an independent advisory body of external experts, established at the very start of the AF-B-STEP project, consisting of John Camm, Jonathan Piccini and Stephen Gilbert.